Stage IIIB Breast Cancer Terminated Phase 1 Trials for Goserelin (DB00014)

IndicationStatusPhase
DBCOND0028549 (Stage IIIB Breast Cancer)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01149356RO4929097 And Exemestane in Treating Pre- and Postmenopausal Patients With Advanced or Metastatic Breast CancerTreatment